Trauson's shares jump 41% on news of Stryker's $764M offer

Yesterday, Stryker ($SYK) agreed to buy China's Trauson Holdings for $764 million, and the devicemaker's shares leapt 41% on the Hong Kong market, a record day for the orthopedics-focused company, according to Bloomberg. Stryker expects to close its acquisition of China's largest orthopedic device firm in the second quarter. Report

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.